Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Download original image
Fig. 3. Eradication rate of Helicobacter pylori with vonoprazan and proton pump inhibitor (PPI). The H. pylori eradication rates by first-line triple therapies from randomized controlled trials are separately shown in clarithromycin (CAM)-sensitive and CAM-resistant subgroups. NS, not significant; VAC, vonoprazan + amoxicillin + clarithromycin; LAC, lansoprazole + amoxicillin + clarithromycin; PAC; PPI (lansoprazole, rabeprazole, or esomeprazole) + amoxicillin + clarithromycin.
Journal of Neurogastroenterology and Motility 2018;24:334~344 https://doi.org/10.5056/jnm18029
© J Neurogastroenterol Motil